Functionally, our findings indicate that BCMA in AML operates similarly to its role in MM - engaging the NF-kB pathway upon ligand binding, thereby activating gene expression programs that support leukemia cell survival and proliferation. Here, TNFRSF17 is linked to Miyoshi myopathy.